Redmile Group as of Dec. 31, 2017
Portfolio Holdings for Redmile Group
Redmile Group holds 69 positions in its portfolio as reported in the December 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Array BioPharma | 10.7 | $245M | 19M | 12.80 | |
| Amicus Therapeutics (FOLD) | 6.3 | $144M | 10M | 14.39 | |
| Puma Biotechnology (PBYI) | 3.9 | $90M | 914k | 98.85 | |
| Clovis Oncology | 3.9 | $90M | 1.3M | 68.00 | |
| Wave Life Sciences (WVE) | 3.4 | $78M | 2.2M | 35.10 | |
| Alder Biopharmaceuticals | 3.2 | $75M | 6.5M | 11.45 | |
| AstraZeneca (AZN) | 3.1 | $70M | 2.0M | 34.70 | |
| Insmed (INSM) | 3.1 | $70M | 2.2M | 31.18 | |
| ImmunoGen | 3.0 | $70M | 11M | 6.41 | |
| Celgene Corporation | 3.0 | $68M | 653k | 104.36 | |
| Seattle Genetics | 2.7 | $62M | 1.2M | 53.50 | |
| Penumbra (PEN) | 2.5 | $58M | 617k | 94.10 | |
| Centene Corporation (CNC) | 2.4 | $55M | 542k | 100.88 | |
| Abbott Laboratories (ABT) | 2.2 | $51M | 897k | 57.07 | |
| Atara Biotherapeutics | 2.2 | $51M | 2.8M | 18.10 | |
| Livanova Plc Ord (LIVN) | 2.1 | $49M | 616k | 79.92 | |
| Regenxbio Inc equity us cm (RGNX) | 2.1 | $47M | 1.4M | 33.25 | |
| Inc Resh Hldgs Inc cl a | 2.0 | $47M | 1.1M | 43.60 | |
| Bluebird Bio | 2.0 | $46M | 260k | 178.10 | |
| Irhythm Technologies (IRTC) | 2.0 | $46M | 815k | 56.05 | |
| Teleflex Incorporated (TFX) | 1.9 | $43M | 173k | 248.82 | |
| Catalent | 1.5 | $34M | 833k | 41.08 | |
| Fate Therapeutics (FATE) | 1.5 | $33M | 5.5M | 6.11 | |
| UnitedHealth (UNH) | 1.4 | $33M | 149k | 220.46 | |
| Oxford Immunotec Global | 1.4 | $32M | 2.3M | 13.97 | |
| Glycomimetics | 1.4 | $32M | 1.9M | 16.79 | |
| Endologix | 1.4 | $32M | 5.9M | 5.35 | |
| ICU Medical, Incorporated (ICUI) | 1.3 | $30M | 140k | 216.00 | |
| Xencor (XNCR) | 1.3 | $30M | 1.4M | 21.92 | |
| WellCare Health Plans | 1.3 | $29M | 144k | 201.11 | |
| Audentes Therapeutics | 1.3 | $29M | 929k | 31.25 | |
| eHealth (EHTH) | 1.2 | $27M | 1.6M | 17.37 | |
| Allscripts Healthcare Solutions (MDRX) | 1.1 | $26M | 1.8M | 14.55 | |
| Universal Health Services (UHS) | 1.1 | $25M | 217k | 113.35 | |
| Epizyme | 1.1 | $24M | 1.9M | 12.55 | |
| Anaptysbio Inc Common (ANAB) | 1.0 | $23M | 230k | 100.72 | |
| Pra Health Sciences | 1.0 | $23M | 251k | 91.07 | |
| Nightstar Therapeutics | 0.9 | $22M | 1.8M | 12.33 | |
| Array Biopharma Inc bond | 0.9 | $22M | 19M | 1.14 | |
| Invitae (NVTAQ) | 0.9 | $20M | 2.2M | 9.08 | |
| Cymabay Therapeutics | 0.8 | $18M | 2.0M | 9.20 | |
| Inflarx Nv (IFRX) | 0.8 | $18M | 857k | 20.95 | |
| Chimerix (CMRX) | 0.8 | $18M | 3.8M | 4.63 | |
| Newlink Genetics Corporation | 0.7 | $17M | 2.1M | 8.11 | |
| Heska Corporation | 0.7 | $16M | 196k | 80.21 | |
| Odonate Therapeutics Ord | 0.7 | $15M | 597k | 25.00 | |
| Deciphera Pharmaceuticals | 0.6 | $15M | 684k | 21.43 | |
| Model N (MODN) | 0.6 | $13M | 854k | 15.75 | |
| Argenx Se (ARGX) | 0.6 | $13M | 200k | 63.14 | |
| Jounce Therapeutics | 0.5 | $13M | 980k | 12.75 | |
| Transenterix | 0.4 | $9.7M | 5.0M | 1.93 | |
| Cytomx Therapeutics (CTMX) | 0.4 | $8.8M | 419k | 21.11 | |
| Globus Med Inc cl a (GMED) | 0.4 | $8.6M | 209k | 41.10 | |
| Syros Pharmaceuticals | 0.3 | $6.2M | 637k | 9.73 | |
| Teladoc (TDOC) | 0.2 | $5.2M | 150k | 34.85 | |
| Proqr Thrapeutics N V shs euro (PRQR) | 0.2 | $5.0M | 1.6M | 3.23 | |
| Petiq (PETQ) | 0.2 | $4.9M | 224k | 21.84 | |
| Ovid Therapeutics (OVID) | 0.1 | $3.1M | 313k | 9.87 | |
| Aclaris Therapeutics (ACRS) | 0.1 | $2.6M | 107k | 24.66 | |
| Cascadian Therapeutics | 0.1 | $2.4M | 649k | 3.70 | |
| BioMarin Pharmaceutical (BMRN) | 0.0 | $223k | 2.5k | 89.20 | |
| Humana (HUM) | 0.0 | $248k | 1.0k | 248.00 | |
| Align Technology (ALGN) | 0.0 | $253k | 1.1k | 221.93 | |
| Nektar Therapeutics | 0.0 | $318k | 5.3k | 59.70 | |
| Pacira Pharmaceuticals (PCRX) | 0.0 | $237k | 5.2k | 45.66 | |
| Vocera Communications | 0.0 | $212k | 7.0k | 30.29 | |
| Horizon Pharma | 0.0 | $292k | 20k | 14.60 | |
| Castlight Health | 0.0 | $38k | 10k | 3.71 | |
| Adverum Biotechnologies | 0.0 | $78k | 22k | 3.51 |